vs
Side-by-side financial comparison of SR Bancorp, Inc. (SRBK) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $8.4M, roughly 1.6× SR Bancorp, Inc.). SR Bancorp, Inc. runs the higher net margin — 10.0% vs -73.9%, a 83.8% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 6.4%). SR Bancorp, Inc. produced more free cash flow last quarter ($3.1M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -2.4%).
SR Bancorp Inc. is a regional bank holding company based in the United States. It offers a full range of consumer and commercial banking services including deposit products, personal loans, mortgage lending, small business financing, and commercial credit solutions, primarily serving local communities and small to mid-sized enterprises in its operating areas.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
SRBK vs TLSI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.4M | $13.2M |
| Net Profit | $834.0K | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | 13.0% | -24.8% |
| Net Margin | 10.0% | -73.9% |
| Revenue YoY | 6.4% | 59.8% |
| Net Profit YoY | -18.3% | 3.5% |
| EPS (diluted) | $0.11 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.4M | $13.2M | ||
| Q3 25 | $8.2M | $11.6M | ||
| Q2 25 | $7.6M | $11.2M | ||
| Q1 25 | $7.7M | $9.2M | ||
| Q4 24 | $7.9M | $8.3M | ||
| Q3 24 | $8.4M | $7.3M | ||
| Q2 24 | $7.9M | $7.4M | ||
| Q1 24 | $8.8M | $6.5M |
| Q4 25 | $834.0K | $-9.8M | ||
| Q3 25 | $693.0K | $-10.8M | ||
| Q2 25 | $2.2M | $-8.3M | ||
| Q1 25 | $537.0K | $-10.4M | ||
| Q4 24 | $1.0M | $-10.1M | ||
| Q3 24 | $1.4M | $-2.4M | ||
| Q2 24 | $-3.0M | $-4.3M | ||
| Q1 24 | $1.1M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | 13.0% | -24.8% | ||
| Q3 25 | 11.0% | -77.9% | ||
| Q2 25 | 32.1% | -65.4% | ||
| Q1 25 | 8.1% | -79.9% | ||
| Q4 24 | 17.1% | -91.8% | ||
| Q3 24 | 20.6% | -118.9% | ||
| Q2 24 | -34.0% | -111.0% | ||
| Q1 24 | 15.4% | -180.8% |
| Q4 25 | 10.0% | -73.9% | ||
| Q3 25 | 8.5% | -93.5% | ||
| Q2 25 | 29.2% | -73.9% | ||
| Q1 25 | 7.0% | -113.2% | ||
| Q4 24 | 13.0% | -122.4% | ||
| Q3 24 | 16.3% | -32.6% | ||
| Q2 24 | -38.2% | -58.8% | ||
| Q1 24 | 12.1% | -204.5% |
| Q4 25 | $0.11 | $-0.22 | ||
| Q3 25 | $0.09 | $-0.96 | ||
| Q2 25 | $0.27 | $-0.27 | ||
| Q1 25 | $0.06 | $-0.39 | ||
| Q4 24 | $0.12 | $-0.38 | ||
| Q3 24 | $0.16 | $-0.12 | ||
| Q2 24 | $8.14 | $-0.21 | ||
| Q1 24 | $0.12 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $81.8M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $188.5M | $-33.9M |
| Total Assets | $1.1B | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $81.8M | $20.4M | ||
| Q3 25 | $58.3M | $22.7M | ||
| Q2 25 | $57.8M | $26.5M | ||
| Q1 25 | $62.2M | $13.0M | ||
| Q4 24 | $53.4M | $8.5M | ||
| Q3 24 | $47.3M | $11.3M | ||
| Q2 24 | $45.9M | $16.5M | ||
| Q1 24 | $72.5M | $4.0M |
| Q4 25 | $188.5M | $-33.9M | ||
| Q3 25 | $191.9M | $-26.7M | ||
| Q2 25 | $193.8M | $-19.4M | ||
| Q1 25 | $195.1M | $-34.4M | ||
| Q4 24 | $198.1M | $-25.9M | ||
| Q3 24 | $200.5M | $-20.4M | ||
| Q2 24 | $199.5M | $-25.3M | ||
| Q1 24 | $199.3M | $-36.0M |
| Q4 25 | $1.1B | $35.3M | ||
| Q3 25 | $1.1B | $36.5M | ||
| Q2 25 | $1.1B | $41.3M | ||
| Q1 25 | $1.1B | $28.6M | ||
| Q4 24 | $1.1B | $24.0M | ||
| Q3 24 | $1.1B | $27.5M | ||
| Q2 24 | $1.0B | $32.4M | ||
| Q1 24 | $1.1B | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.6M | $-2.5M |
| Free Cash FlowOCF − Capex | $3.1M | $-2.5M |
| FCF MarginFCF / Revenue | 37.0% | -19.1% |
| Capex IntensityCapex / Revenue | 5.9% | 0.3% |
| Cash ConversionOCF / Net Profit | 4.31× | — |
| TTM Free Cash FlowTrailing 4 quarters | $11.0M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | $-2.5M | ||
| Q3 25 | $1.2M | $-3.7M | ||
| Q2 25 | $4.7M | $-7.3M | ||
| Q1 25 | $2.6M | $-4.5M | ||
| Q4 24 | $-1.4M | $-5.7M | ||
| Q3 24 | $1.8M | $-10.8M | ||
| Q2 24 | $-1.7M | $-13.4M | ||
| Q1 24 | $-3.9M | $-10.9M |
| Q4 25 | $3.1M | $-2.5M | ||
| Q3 25 | $1.1M | $-3.9M | ||
| Q2 25 | $4.2M | $-7.4M | ||
| Q1 25 | $2.5M | $-5.3M | ||
| Q4 24 | $-1.5M | $-5.8M | ||
| Q3 24 | $1.7M | $-11.0M | ||
| Q2 24 | $-2.8M | $-13.5M | ||
| Q1 24 | $-4.0M | $-10.9M |
| Q4 25 | 37.0% | -19.1% | ||
| Q3 25 | 14.0% | -33.9% | ||
| Q2 25 | 55.9% | -66.1% | ||
| Q1 25 | 32.3% | -57.3% | ||
| Q4 24 | -19.5% | -69.7% | ||
| Q3 24 | 20.3% | -149.9% | ||
| Q2 24 | -35.8% | -183.1% | ||
| Q1 24 | -45.2% | -169.3% |
| Q4 25 | 5.9% | 0.3% | ||
| Q3 25 | 0.9% | 1.9% | ||
| Q2 25 | 5.7% | 0.8% | ||
| Q1 25 | 1.0% | 8.2% | ||
| Q4 24 | 1.3% | 0.6% | ||
| Q3 24 | 1.0% | 2.3% | ||
| Q2 24 | 13.9% | 0.8% | ||
| Q1 24 | 0.5% | 1.0% |
| Q4 25 | 4.31× | — | ||
| Q3 25 | 1.76× | — | ||
| Q2 25 | 2.11× | — | ||
| Q1 25 | 4.79× | — | ||
| Q4 24 | -1.40× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.69× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
